Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 24522930)

1.

Structural stability of influenza A(H1N1)pdm09 virus hemagglutinins.

Yang H, Chang JC, Guo Z, Carney PJ, Shore DA, Donis RO, Cox NJ, Villanueva JM, Klimov AI, Stevens J.

J Virol. 2014 May;88(9):4828-38. doi: 10.1128/JVI.02278-13. Epub 2014 Feb 12.

2.

Molecular characterization of the predominant influenza A(H1N1)pdm09 virus in Mexico, December 2011-February 2012.

de la Rosa-Zamboni D, Vázquez-Pérez JA, Avila-Ríos S, Carranco-Arenas AP, Ormsby CE, Cummings CA, Soto-Nava M, Hernández-Hernández VA, Orozco-Sánchez CO, la Barrera CA, Pérez-Padilla R, Reyes-Terán G.

PLoS One. 2012;7(11):e50116. doi: 10.1371/journal.pone.0050116. Epub 2012 Nov 29.

3.

Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines.

Lu Y, Welsh JP, Swartz JR.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):125-30. doi: 10.1073/pnas.1308701110. Epub 2013 Dec 16.

4.

Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines.

Xuan C, Shi Y, Qi J, Zhang W, Xiao H, Gao GF.

Protein Cell. 2011 Dec;2(12):997-1005. doi: 10.1007/s13238-011-1134-y. Epub 2012 Jan 10. Erratum in: Protein Cell. 2012 Feb;3(2):160.

PMID:
22231357
5.

The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines.

O'Donnell CD, Vogel L, Matsuoka Y, Jin H, Subbarao K.

J Virol. 2014 Nov;88(21):12374-84. doi: 10.1128/JVI.01107-14. Epub 2014 Aug 13.

6.

Intermonomer Interactions in Hemagglutinin subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.

Wang W, DeFeo CJ, Alvarado E, Vassell R, Weiss CD.

J Virol. 2015 Aug 12. pii: JVI.00939-15. [Epub ahead of print]

PMID:
26269180
7.

Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability.

Feshchenko E, Rhodes DG, Felberbaum R, McPherson C, Rininger JA, Post P, Cox MM.

BMC Biotechnol. 2012 Oct 30;12:77. doi: 10.1186/1472-6750-12-77.

8.

Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions.

de Vries RP, de Vries E, Martínez-Romero C, McBride R, van Kuppeveld FJ, Rottier PJ, García-Sastre A, Paulson JC, de Haan CA.

J Virol. 2013 Dec;87(24):13868-77. doi: 10.1128/JVI.01955-13. Epub 2013 Oct 9.

9.

Structural and antigenic variance between novel influenza A/H1N1/2009 and influenza A/H1N1/2008 viruses.

Saxena SK, Mishra N, Saxena R, Swamy ML, Sahgal P, Saxena S, Tiwari S, Mathur A, Nair MP.

J Infect Dev Ctries. 2009 Nov 26;4(1):1-6.

10.

Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage.

Wang W, Suguitan AL Jr, Zengel J, Chen Z, Jin H.

Vaccine. 2012 Jan 20;30(5):872-8. doi: 10.1016/j.vaccine.2011.11.101. Epub 2011 Dec 13.

PMID:
22172510
11.

Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin.

Weldon WC, Wang BZ, Martin MP, Koutsonanos DG, Skountzou I, Compans RW.

PLoS One. 2010 Sep 1;5(9). pii: e12466. doi: 10.1371/journal.pone.0012466.

12.

A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity.

Cotter CR, Jin H, Chen Z.

PLoS Pathog. 2014 Jan;10(1):e1003831. doi: 10.1371/journal.ppat.1003831. Epub 2014 Jan 2.

13.

Molecular characterization and phylogenetic analysis of the hemagglutinin 1 protein of human influenza A virus subtype H1N1 circulating in Kenya during 2007-2008.

Bulimo WD, Achilla RA, Majanja J, Mukunzi S, Wadegu M, Osunna F, Mwangi J, Njiri J, Wangui J, Nyambura J, Obura B, Mitei K, Omariba D, Segecha S, Nderitu M, Odindo A, Adega C, Kiponda J, Mupa R, Munyazi F, Kissinger G, Mwakuzimu M, Kamola D, Muhidin E, Kamau D, Kairithia S, Koech M, Sang A, Onge'ta L, Schnabel DC.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S46-52. doi: 10.1093/infdis/jis586.

14.

Attenuated influenza virus construct with enhanced hemagglutinin protein expression.

Maamary J, Pica N, Belicha-Villanueva A, Chou YY, Krammer F, Gao Q, García-Sastre A, Palese P.

J Virol. 2012 May;86(10):5782-90. doi: 10.1128/JVI.00190-12. Epub 2012 Mar 7.

15.

Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.

Hong M, Lee PS, Hoffman RM, Zhu X, Krause JC, Laursen NS, Yoon SI, Song L, Tussey L, Crowe JE Jr, Ward AB, Wilson IA.

J Virol. 2013 Nov;87(22):12471-80. doi: 10.1128/JVI.01388-13. Epub 2013 Sep 11.

16.

Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.

Schmeisser F, Friedman R, Besho J, Lugovtsev V, Soto J, Wang W, Weiss C, Williams O, Xie H, Ye Z, Weir JP.

Influenza Other Respir Viruses. 2013 May;7(3):480-90. doi: 10.1111/irv.12029. Epub 2012 Nov 5.

PMID:
23122228
17.

Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates.

Ding X, Jiang L, Ke C, Yang Z, Lei C, Cao K, Xu J, Xu L, Yang X, Zhang Y, Huang P, Huang W, Zhu X, He Z, Liu L, Li J, Yuan J, Wu J, Tang X, Li M.

Virus Genes. 2010 Dec;41(3):329-40. doi: 10.1007/s11262-010-0526-z. Epub 2010 Aug 31.

PMID:
20809098
18.

Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution.

Kim JI, Lee I, Park S, Hwang MW, Bae JY, Lee S, Heo J, Park MS, García-Sastre A, Park MS.

J Virol. 2013 Jul;87(13):7539-49. doi: 10.1128/JVI.00373-13. Epub 2013 May 1.

19.

Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs.

Suphaphiphat P, Franti M, Hekele A, Lilja A, Spencer T, Settembre E, Palmer G, Crotta S, Tuccino AB, Keiner B, Trusheim H, Balabanis K, Sackal M, Rothfeder M, Mandl CW, Dormitzer PR, Mason PW.

Virol J. 2010 Jul 14;7:157. doi: 10.1186/1743-422X-7-157.

20.

Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin.

Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, Takada A.

PLoS One. 2010 Jan 1;5(1):e8553. doi: 10.1371/journal.pone.0008553.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk